Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags

Breukels, Oscar; van, der Gronde Toon; Simons-Sanders, Kathleen; Crul, Mirjam

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags

Author(s): Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam

Issue: Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Page(s): 345-349

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 1

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 2

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 3

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 4

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Page 5

Download in electronic PDF format for $75

Abstract: Eight Dutch hospital pharmacies took wipe samples of prepared infusion bags containing 5 fluorouracil just before distribution to the wards. The samples were tested with high-performance liquid chromatography and triple quadrupole mass spectroscopy. The limit of detection was 10 ng per swipe. None of the 146 samples had a detectable amount of 5-fluorouracil. The outside of infusion bags containing antineoplastic drugs prepared in these eight Dutch hospital pharmacies were not contaminated and, therefore, were not a risk factor with regard to exposure of hospital workers to antineoplastic drugs.

Related Keywords: hospital pharmacy, prepared infusion bags, 5-fluorouracil, compounded cytotoxic agents, occupational exposure, workplace exposure, antineoplastic drugs, hazardous drugs, wipe tests, infusion bag contamination

Related Categories: CANCER AND AIDS, INFUSION, PACKAGING, PEER-REVIEWED, QUALITY CONTROL, HAZARDOUS DRUGS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam	Jul/Aug 2018 Pg. 345-349
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Allen Loyd V Jr	Nov/Dec 2006 Pg. 446-448
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A	Sep/Oct 2007 Pg. 426-432
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P	Nov/Dec 2021 Pg. 515-522
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P	Jan/Feb 2022 Pg. 72-79
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting McElhiney Linda F	Jul/Aug 2009 Pg. 300-310
How to Develop and Maintain a Hazardous Drug List Dillon L Rad	May/Jun 2019 Pg. 182-186
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> Allen Loyd V Jr	Sep/Oct 2021 Pg. 356
Compounding Using Hazardous Drugs Lau Kellie	Jul/Aug 2000 Pg. 261-263
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags Xu Quanyun A, Trissel Lawrence A, Saenz Christopher A, Ingram Delshalonda S	Mar/Apr 2002 Pg. 152-154
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations Allen Loyd V Jr	Mar/Apr 2007 Pg. 149-151
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott	Nov/Dec 2020 Pg. 519-527
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Palma Elisabetta, Bufarini Celestino	Sep/Oct 2014 Pg. 358-364
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra	Sep/Oct 2015 Pg. 432-436
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Lopez C Vidal, Rios GL Quito	Sep/Oct 2022 Pg. 358-362
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Kaiser Jeanette, Kramer Irene	Nov/Dec 2011 Pg. 515-520
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction Allen Loyd V Jr	Sep/Oct 2006 Pg. 377-379
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D	May/Jun 2003 Pg. 233-239
Return to Top